Investors
Key press releases
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$3.9800
-0.5400 (-11.9469%)
- Prev. close
- 4.5200
- Volume
- 219,046
- High
- 4.4100
- Capitalization
- 286.933M
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€3.4100
-0.6550 (-16.1132%)
- Prev. close
- 4.0650
- Volume
- 1.684M
- High
- 4.1300
- Capitalization
- 245.839M
Covering research analysts
Barclays - Gena Wang
Bryan Garnier - Oscar Haffen-Lamm
Goldman Sachs - Salveen Richter
Jefferies - Kelly Shi
JMP Securities - Silvan Tuerkcan
Jones Trading - Soumit Roy
Kempen - Sebastiaan van der Schoot
Oddo BHF - Martial Descoutures
RW Baird - Jack Allen
Wells Fargo – Yanan Zhu
Cellectis contact information
Arthur Stril, Chief Financial Officer & Chief Business Officer
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89